Singhal Priya's Form 4 filing
Biogen Inc.BIIB · filed Apr 6, 2023
- Accession no.
- 0001127602-23-012691
- Filed
- Apr 6, 2023
- Trade date
- Apr 4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $25.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | Common Stock | SSaleDisposed | −91 | $277.11F1 | −$25,217.01 | 2,843.09 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan.
Referenced by the price of 1 transaction in Table I.